Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubChem Substance

Items: 1 to 20 of 637

1.

Brown-fat paucity due to impaired BMP signalling induces compensatory browning of white fat.

Schulz TJ, Huang P, Huang TL, Xue R, McDougall LE, Townsend KL, Cypess AM, Mishina Y, Gussoni E, Tseng YH.

Nature. 2013 Mar 21;495(7441):379-83. doi: 10.1038/nature11943. Epub 2013 Mar 13.

2.

Fine-tuning BMP7 signalling in adipogenesis by UBE2O/E2-230K-mediated monoubiquitination of SMAD6.

Zhang X, Zhang J, Bauer A, Zhang L, Selinger DW, Lu CX, Ten Dijke P.

EMBO J. 2013 Apr 3;32(7):996-1007. doi: 10.1038/emboj.2013.38. Epub 2013 Mar 1.

3.

Screening of indigenous goats for prolificacy associated DNA markers of sheep.

Ahlawat S, Sharma R, Maitra A.

Gene. 2013 Mar 15;517(1):128-31. doi: 10.1016/j.gene.2012.12.015. Epub 2013 Jan 5.

PMID:
23299026
4.

Competitive balance of intrabulge BMP/Wnt signaling reveals a robust gene network ruling stem cell homeostasis and cyclic activation.

Kandyba E, Leung Y, Chen YB, Widelitz R, Chuong CM, Kobielak K.

Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1351-6. doi: 10.1073/pnas.1121312110. Epub 2013 Jan 4.

5.

Type Ib BMP receptors mediate the rate of commissural axon extension through inhibition of cofilin activity.

Yamauchi K, Varadarajan SG, Li JE, Butler SJ.

Development. 2013 Jan 15;140(2):333-42. doi: 10.1242/dev.089524.

6.

BMP receptor 1A regulates development of hypothalamic circuits critical for feeding behavior.

Peng CY, Mukhopadhyay A, Jarrett JC, Yoshikawa K, Kessler JA.

J Neurosci. 2012 Nov 28;32(48):17211-24. doi: 10.1523/JNEUROSCI.2484-12.2012.

7.

BMP-6 and BMPR-1a are up-regulated in the growth plate of the fractured tibia.

Fischerauer EE, Manninger M, Seles M, Janezic G, Pichler K, Ebner B, Weinberg AM.

J Orthop Res. 2013 Mar;31(3):357-63. doi: 10.1002/jor.22238. Epub 2012 Oct 23.

8.

BMP4 is a novel paracrine inhibitor of liver regeneration.

Do N, Zhao R, Ray K, Ho K, Dib M, Ren X, Kuzontkoski P, Terwilliger E, Karp SJ.

Am J Physiol Gastrointest Liver Physiol. 2012 Dec 1;303(11):G1220-7. doi: 10.1152/ajpgi.00105.2012. Epub 2012 Sep 27.

9.

Negative mutation screening of the NOG, BMPR1B, GDF5, and FGF9 genes indicates further genetic heterogeneity of the facioaudiosymphalangism syndrome.

van den Ende JJ, Borra V, Van Hul W.

Clin Dysmorphol. 2013 Jan;22(1):1-6. doi: 10.1097/MCD.0b013e3283590986.

PMID:
22968293
10.

Juvenile polyposis syndrome: a study of genotype, phenotype, and long-term outcome.

Latchford AR, Neale K, Phillips RK, Clark SK.

Dis Colon Rectum. 2012 Oct;55(10):1038-43. doi: 10.1097/DCR.0b013e31826278b3.

PMID:
22965402
11.

SMAD versus non-SMAD signaling is determined by lateral mobility of bone morphogenetic protein (BMP) receptors.

Guzman A, Zelman-Femiak M, Boergermann JH, Paschkowsky S, Kreuzaler PA, Fratzl P, Harms GS, Knaus P.

J Biol Chem. 2012 Nov 16;287(47):39492-504. doi: 10.1074/jbc.M112.387639. Epub 2012 Sep 7.

12.

[Juvenile polyposis syndrome].

Vasovčák P, Foretová L, Puchmajerová A, Křepelová A.

Klin Onkol. 2012;25 Suppl:S16-7. Slovak.

PMID:
22920200
13.

Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.

Wu X, Zhang N, Lee MM.

Endocrinology. 2012 Oct;153(10):4929-37. Epub 2012 Aug 7.

14.

Inhibitory effect of adenovirus-mediated siRNA-targeting BMPR-IB on UHMWPE-induced bone destruction in the murine air pouch model.

Wang Y, Wu NN, Hu M, Mou YQ, Li RD, Chen L, He BC, Deng ZL.

Connect Tissue Res. 2012;53(6):528-34. doi: 10.3109/03008207.2012.702817. Epub 2012 Jul 24.

PMID:
22827452
15.

Structure of the Alk1 extracellular domain and characterization of its bone morphogenetic protein (BMP) binding properties.

Mahlawat P, Ilangovan U, Biswas T, Sun LZ, Hinck AP.

Biochemistry. 2012 Aug 14;51(32):6328-41. Epub 2012 Aug 2.

16.

LRP1-dependent endocytic mechanism governs the signaling output of the bmp system in endothelial cells and in angiogenesis.

Pi X, Schmitt CE, Xie L, Portbury AL, Wu Y, Lockyer P, Dyer LA, Moser M, Bu G, Flynn EJ 3rd, Jin SW, Patterson C.

Circ Res. 2012 Aug 17;111(5):564-74. doi: 10.1161/CIRCRESAHA.112.274597. Epub 2012 Jul 9.

17.

Reduced bone morphogenetic protein receptor type 1A signaling in neural-crest-derived cells causes facial dysmorphism.

Saito H, Yamamura K, Suzuki N.

Dis Model Mech. 2012 Nov;5(6):948-55. doi: 10.1242/dmm.009274. Epub 2012 Jul 5.

18.

A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.

Baud'huin M, Solban N, Cornwall-Brady M, Sako D, Kawamoto Y, Liharska K, Lath D, Bouxsein ML, Underwood KW, Ucran J, Kumar R, Pobre E, Grinberg A, Seehra J, Canalis E, Pearsall RS, Croucher PI.

Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):12207-12. doi: 10.1073/pnas.1204929109. Epub 2012 Jul 3.

19.

Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy.

Shi S, de Gorter DJ, Hoogaars WM, 't Hoen PA, ten Dijke P.

Cell Mol Life Sci. 2013 Feb;70(3):407-23. doi: 10.1007/s00018-012-1054-x. Epub 2012 Jul 4. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk